Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology ·Vol. 9 ·No. 12 ·1990-12-00 ·Pages 905-6

Pérez-Trallero E, Garcia-Arenzana JM, Jimenez JA, Peris A

Abstract

暂无摘要

MeSH Terms

Aged Aged, 80 and over Anti-Infective Agents/therapeutic use Ciprofloxacin/therapeutic use Drug Resistance, Microbial Humans Male Pneumonia, Pneumococcal/drug therapy Serotyping Streptococcus pneumoniae/classification,drug effects

Chemicals

Anti-Infective Agents Ciprofloxacin

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Pérez-Trallero E

Garcia-Arenzana J M

Jimenez J A

Peris A

References (4)

4 references, click to expand

Clinical use of the quinolones.
Lancet. 1987 Dec 5;2(8571):1319-22 PMID: 2890913
Penetration of ciprofloxacin into bronchial secretions.
Eur J Clin Microbiol. 1986 Apr;5(2):197-200 PMID: 2941280
In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.
Antimicrob Agents Chemother. 1987 Oct;31(10):1651-5 PMID: 3435111
In vitro activity of ciprofloxacin against gram-positive cocci.
Am J Med. 1987 Apr 27;82(4A):27-32 PMID: 3578323

Article Info

Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Abbr.

Eur J Clin Microbiol Infect Dis

ISSN

0934-9723

DOI

10.1007/BF01967510

Published

1990-12-00

Pages

905-6

Language

English

Region

Germany

NLM ID

8804297

Subset

External Links

PubMed source DOI: 10.1007/BF01967510 View journal details

Analysis Services

Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

Contact

WeChat Official Account